| pubmed-article:9416852 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0021753 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0225369 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0033692 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0521339 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0012472 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C1704264 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C0150312 | lld:lifeskim |
| pubmed-article:9416852 | lifeskim:mentions | umls-concept:C1454054 | lld:lifeskim |
| pubmed-article:9416852 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:9416852 | pubmed:dateCreated | 1998-1-14 | lld:pubmed |
| pubmed-article:9416852 | pubmed:abstractText | Recombinant human osteogenic protein 1 (OP-1) is an effective stimulator of human cartilage 35S-proteoglycan synthesis. The present study was conducted to determine whether stimulation of human articular chondrocytes with OP-1 can help overcome interleukin-1beta (IL-1beta)-induced suppression of 35S-proteoglycan synthesis. | lld:pubmed |
| pubmed-article:9416852 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9416852 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9416852 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9416852 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9416852 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:ThonarE JEJ | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:KuettnerK EKE | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:AydelotteM... | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:SampathT KTK | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:MollenhauerJJ | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:WilbrinkBB | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:HuckLL | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:Flechtenmache... | lld:pubmed |
| pubmed-article:9416852 | pubmed:author | pubmed-author:KoeppH EHE | lld:pubmed |
| pubmed-article:9416852 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9416852 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:9416852 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9416852 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9416852 | pubmed:pagination | 2157-61 | lld:pubmed |
| pubmed-article:9416852 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:meshHeading | pubmed-meshheading:9416852-... | lld:pubmed |
| pubmed-article:9416852 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9416852 | pubmed:articleTitle | Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. | lld:pubmed |
| pubmed-article:9416852 | pubmed:affiliation | Rush Medical College at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. | lld:pubmed |
| pubmed-article:9416852 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9416852 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9416852 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9416852 | lld:pubmed |
